Perkembangan Vaksin COVID-19 Produksi Dalam Negeri
Pengembangan vaksin COVID-19 produksi dalam negeri melalui kerja sama dengan BUMN maupun perusahaan swasta terus berjalan, dan diharapkan dapat diedarkan dan digunakan pada 2022.
| ABX | ||
| 2,588.223 | ||
| -155.9590 | -0.0568% | |
| BISNIS-27 | ||
| 508.220 | ||
| -20.7600 | -0.0392% | |
| DBX | ||
| 3,534.620 | ||
| -205.9580 | -0.0551% | |
| ECONOMIC30 | ||
| 105.035 | ||
| -5.0130 | -0.0456% | |
| ESGQKEHATI | ||
| 120.983 | ||
| -3.9070 | -0.0313% | |
| ESGSKEHATI | ||
| 122.652 | ||
| -3.8820 | -0.0307% | |
| I-GRADE | ||
| 199.320 | ||
| -8.5810 | -0.0413% | |
| AUDRP | ||
| 11,932.080 | ||
| 66.0000 | 0.5562% | |
| EURRP | ||
| 19,640.660 | ||
| 49.3900 | 0.2521% | |
| JPYRP | ||
| 107.573 | ||
| 0.6124 | 0.5725% | |
| SINRP | ||
| 13,242.120 | ||
| 36.1100 | 0.2734% | |
| USDRP | ||
| 16,889.000 | ||
| 17.0000 | 0.1008% | |
